Developing innovative drugs is no easy feat. For years, the industry has battled three major pain points: long cycles, staggering costs, and high failure rates. Lengthy pipelines and endless wet-lab ...
Flex and Cerebras Systems Inc. today announced an expanded manufacturing partnership to scale production of the Cerebras CS-3, one of the world's most advanced AI accelerator systems, at Flex ...